Thank you for sharing your well articulated blog post.
I found it realy inspiring and very much inline with my understanding of the opportunities that abound with digital technology from both a B2B as well as B2C perspective.

One "broken" industry that stands to benefit significantly from digital distruption is the US Healthcare Industry, that has been so fragmented, wih extremely valauble information kept in localized 'pockets' around the country. We now have the ability share data, EHRs, lab results, diagnoses and teh ability to evaluate which therapies work for which patient groups.

But I question that Pharma will experience the least amount of digital disruption, especially now that technology helped us to 'crack' the human genome and recently the human microbiome; we also have advanced stem cell technoligies, invitro as well as cryogenics, and a myriad individual medical devices to diagnose, track, and evaluate our conditions.

We can't forget that digital technologies are enabling healthcare providers to evaluate more patient dynamics and more information - in fact, many integrative HCPs are now looking at the patient as a whole person as opposed to just treating their symtoms - and as such they are already engaging "Functional Medicine" therby getting to the Root Cause of the issue.

The future is not one-size-fits-all but a system that offers personalized solutions.

Society is finally embracing the Hypocratic philosophy; "Let food be thy medicine" so with the shift to healthier whole foods, active-lifestyles and stress reduction, we will see much less infammation - the root cause of most chronic disease.

So while it could be correct that the Pharma industry might have the least to worry about from digital distruption from within its industry, I believe that digital technloiges have helped alternative solutions to pharmaceuticals thrive - and consumers are demanding this better alternative.